Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRAS pathway mutation is an added‐value biomarker in pediatric Philadelphia‐negative B‐cell acute lymphoblastic leukemia with IKZF1 deletions.AuthorsHuang, Ying‐Jung; Liu, Hsi‐Che; Jaing, Tang‐Her; Wu, Kang‐Hsi; Wang, Shih‐Chung; Yen, Hsiu‐Ju; Hsiao, Chih‐Cheng; Chen, Shih‐Hsiang; Lin, Pei‐Chin; Yeh, Ting‐Chi; Sheen, Jiunn‐Ming; Chen, Yu‐Chieh; Chang, Te‐Kau; Huang, Fang‐Liang; Chao, Yu‐Hua; Hou, Jen‐Yin; Yang, Chao‐Ping; Lin, Tung‐Huei; Shih, Lee‐YungPublicationPediatric Blood & Cancer, 2021, Vol 68, Issue 4, p1ISSN1545-5009Publication typeArticleDOI10.1002/pbc.28899